吳肇卿教授：
1. Cheng PN, Wu IC, Wang RH, Wu JC, Tseng KC, Young KC, Chang TT.
Seroprevalence of
hepatitis E virus infection among institutionalized psychiatric patients in Taiwan.
J Clin Virol
2007;38:44-48. 1 citation.
2. Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui
WY, Lee SD.
Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor
as tumor
markers for hepatocellular carcinoma. Eur J Surg Oncol 2007;33:208-212. 18
citations.
3. Wang SY, Wu JC*, Chiang TY, Huang YH, Su CW, Sheen IJ. Positive selection
of hepatitis delta antigen in chronic hepatitis D patients. J Virol
2007;81:4438-4444. 7 citations. cited by Purdy, Michael A. "Phylogenetics
and Medicinal Protein Engineering." Medicinal Protein Engineering. Ed.
Yury E. Khudyakov. Boca Raton: Taylor & Francis, 2008: 63.
4. Huo TI, Huang YH, Chiang JH, Wu JC, Lee PC, Chi CW, Lee SD. Survival
impact of delayed
treatment in patients with hepatocellular carcinoma undergoing locoregional
therapy: is there a lead-time bias? Scan J Gastroenterol 2007;42:485-492. 3
citations.
5. Huo TI, Hsia CY, Chu CJ, Huang YH, Lui WY, Wu JC, Lee PC, Chi CW, Lee
SD. The
predictive ability of serum -fetoprotein for hepatocellular carcinoma is linked
with the characteristics of the target population at surveillance. J Surg Oncol
2007;95:645-651. 2 citations
6. Huo TI, Lin HC, Hsia CY, Wu JC, Lee PC, Chi CW, Lee SD. The model for
end-stage liver
disease based on cancer staging system are better prognostic models for
hepatocellular carcinoma: a prospective sequential survey. Am J Gastroenterol
2007;102:1920-1930. 21 citations.
7. Su CW, Wu JC*, Chiu YY, Tsay SH, Huo TI, Huang YS, Lin HC, Lee SD.
Successful
radiofrequency ablation therapy for hepatocellular carcinoma in a male patient
with early stage primary biliary cirrhosis and positive serum hepatitis B virus
core antibody. J Chin Med Assoc 2008;71:40-44. 1 citation
8. Shih HH, Jeng KS, Syu WJ, Huang YH, Su CW, Peng WL, Wu JC*. Hepatitis
B virus
surface antigen levels and sequences of natural hepatitis B virus variants
influence the assembly and secretion of hepatitis D virus. J Virol
2008;82:2250-2264. 9 citations. Cited by Inc Icon Group International “Virology:
Webster’s Facts and Phrases”.
9. Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu
JC*. Natural
History and Prognostic Factors of Primary Biliary Cirrhosis in Taiwan: A
Follow-up study Up to 18 Years. Liver Int 2008;28(9):1305-1313. 5 citations
10. Chung YC, Ho MS, Wu JC, Chen WJ, Huang JH, Chou ST, Hu YC.
Immunization with
virus-like particles of Enterovirus 71 elicits potent immune responses and
protects mice against lethal challenge. Vaccine 2008;26(15):1855-1862. 30
citations.
11. Huang HC, Wu JC,* Huang YS, Huo TI, Lo JC, Li CP, Chang FY, Shou-Dong
Lee SD.
Genetic distinctions and clinical characteristics of type 1 autoimmune hepatitis in
Taiwan. Hepatogastroenterol 2008;55(82-83):605-608. 2 citations.
12. Huo TI, Lin HC, Huo SC, Lee PC, Wu JC, Lee FY, Hou MC, Lee SD.
Comparison of four
models for end-stage disease-based prognostic systems for cirrhosis. Liver
Transpl 2008;14:837-844. 15 citations.
13. Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Choiou YY, Lui
WY, Lee PC,
Lee SD. The MELD-Na is an independent short- and long-term prognostic
predictor for hepatocellular carcinoma: a prospective study. Dig Liver Dis
2008;40:882-889. 4 citations.
14. Lang HC, Wu JC, Yeh SH, Lan CF, Wu SL. The lifetime cost of hepatocellular
carcinoma: a
claim data analysis from a medical center in Taiwan. Appl Health Econ Health
Policy 2008;6:55-65.
15. Tang CP, Shiau YT, Huang YH, Tsay SH, Huo TI, Wu JC, Lin HC, Lee SD.
Cholestatic jaundice as the predominant presentation in a patient with
autoimmune hepatitis. J Chin Med Assoc 2008;71(1):45-48. 1 citation.
16. Chou CH, Fuh JL, Hu HH, Wu JC, Wang SJ. Throbbing Pain Is Related to the
Queckenstedt’s Test Effect in Migraine Patients. Cephalalgia. 2009;29:373-8.
16. Tseng CW, Su CW, Huang HC, Wu JC, Lin HC. Autoimmune Hepatitis
Combined
with Multiple Virus Infections. Eur J Gastroenterol 2009;20(11):1122-3. 1
citation.
17. Is Entecavir Ideal for the Treatment of Lamivudine-Refractory Chronic Hepatitis
B? Hepatology 2008;48(5):1726-1727. (letter).
17. Su CW, Chan CC, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Tsay SH, Lee
PC, Lee SD,
Wu JC*. Predictive Value of Aspartate Aminotransferase to Alanine
Aminotransferase Ratio
(AAR) for Hepatic Fibrosis and Clinical Adverse Outcomes in Patients with
Primary Biliary
Cirrhosis. J Clin Gastroenterol 2009;43:876-883. 2 citations.
18. Huang YH*, Wu JC*, Peng WL, Huo TI, Shih HH, Lan KH, Su CW, Lee SD.
Generation of
Cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope
modification.
J Hepatol 2009;50:779-788. *equal contribution
19. Chainuvati S*, Cheng J*, Hou J*, Hsu CW*, Jia J*, Komolmit P*, Kwon SY*,
Lee CH*, Li
H*, Li Y*, Liu CJ*, Neo BL*, Peng CY*, Tanwandee T*, Wongcharatrawee *,
Wu JC*, Yu
ML*, Zhang X*. Patterns of Managing Chronic Hepatitis B (CHB)
Treatment-Related Drug
Resistance: A Survey of Physicians in China, South Korea, Taiwan, and
Thailand.
Hepatology Int 2009;3:453-460. *equal contribution. 1 citation
20. Wu JC*, Huang YH, Chau GY, Su CW, Lai CL, Lee PC, Huo TI, Sheen IJ, Lee
SD, Lui WY. Risk factors for early and late recurrence in hepatitis B-related
hepatocellular carcinoma. J Hepatol 2009;51:890-7. (IF: 7.056, 5/55). With an
editorial. 12 citations.
21. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu
JC*. A
Comprehensive Analysis of the Independent Effect of Twist and Snail in
Promoting Metastasis
of Hepatocellular Carcinoma. Hepatology 2009;50:1464-1474. 22 citations. With
an editorial. Selected to take part in the article-level PR program for the
journal Hepatology.
22. Su WW, Chen CH, Lin HH, Yang SS, Chang TT, Cheng KS, Wu JC, Wu SS,
Lee CM,
Changchien CS, Chen CJ, Sheu JC, Chen DS, Lu SN. Geographic variations of
predominantly
hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan:
identification
of potential high HCV endemic areas. Hepatology Int 2009;3(4):537-543. 1
citation.
23. Shih HH, Shih C, Wang HW, Su CW, Sheen IJ, Wu JC*. Reactivation of hepatitis
B virus after transarterial chemo-embolization for hepatocellular carcinoma in one
patient with negative hepatitis B surface antigen. J Gen Virol 2010;91:1004-1012. 1
citation .
24. Hung HH, Su CW, Wu JC, Lee SD. Reactivation of hepatitis B virus after
transarterial
chemo-embolization for hepatocellular carcinoma in one patient with negative
hepatitis B
surface antigen. J Hepatol 2010;52:463–465. (letter)
25. Chen PC, Pang VF, Hsia SH, Chang TC, Chang CC, Chang CH, Wu JC, Jeng
CR. Detection
of hepatitis E virus (HEV) infection in pigs, zoo animals and environmental
rodents in Taiwan.
Taiwan Vet J 2010;36:124-131.
26. Kao WY, Hung HH, Lu HC, Lin HC, Wu JC, Lee SD, Su CW*.
Hepatocellular Carcinoma
with the Presentation of Budd-Chiari Syndrome. J Chin Med Assoc
2010;73:93–96.
27. Hung HH, Huang DF, Tzeng CH, Su CH, Su TP, Chen HC, Tsay SH, Lin HC,
Wu JC, Lee
SD, Su CW. Systemic Amyloidosis Manifesting As a Rare Cause of Hepatic
Failure. J Chin
Med Assoc 2010;73(3):161–165.
28. Chen SP, Fuh JL, Wang SJ, Chang FC, Lirng JF, Fang YC, Shia BC, Wu JC.
Magnetic
Resonance Angiography in Reversible Cerebral Vasoconstriction Syndromes.
Ann Neurol
2010;67(5):648-56. 2 citations
29. Su CW, Hung HH, Lai CR, Chau GY, Huang YH, Huo TI, Lee PC, Kao WY,
Lee SD, Wu
JC*. Fibrosis and AST to Platelet Ratio Index Predict Prognosis for Solitary
Small
Hepatitis-B Related Hepatocellular Carcinoma. Hepatology Int 2010 (in press).
30. Lee IC, Huang YH, Chan CC, Huo TI, Chu CJ, Lai CR, Lee PC, Su CW, Hung
HH, Wu JC,
Lin HC, Lee SD. Correlation between Clinical Indication for Treatment and
Liver Histology
in HBeAg-negative Chronic Hepatitis B: A novel role of alpha-fetoprotein. Liver
Int
2010;30:1161-1168.
31. Hung HH, Chiou YY, Hsia CY, Su CW, Chou YH, Chiang JH, Kao WY, Huo TI,
Huang YH,
Su YH, Lin HC, Lee SD, Wu JC*. Survival Rates Are Comparable Following
Radiofrequency
Ablation or Surgery in Patients with Small Hepatocellular Carcinomas. Clin
Gastrolenterol
Hepatol 2010 (in press). (IF 5.642, ranking 7/65).
32. Lan MY, Chen CL, Lin KT, Lee SA, Yang WL, Hsu CN, Wu JC, Ho CY, Lin JC,
Huang CY.
From NPC therapeutic target identification to potential treatment strategy. Mol
Cancer Ther.
2010;9(9):2511-23.
33. Chou CH, Fuh JL, Wu JC, Wang SJ. Comparison of self-reported cutaneous
allodynia and
brushing allodynia during migraine attacks. Cephalalgia. 2010;30(6):682-5.
34. Lee IC, Chan CC, Huang YH, Huo TI, Chu CJ, Lai CR, Lee PC, Su CW, Hung
HH, Wu JC,
Lin HC, Lee SD. Comparative Analysis of Noninvasive Models to Predict Early
Liver Fibrosis
in Hepatitis B e Antigen-negative Chronic Hepatitis B. J Clin Gastroenterol. 2010
May 25.
[Epub ahead of print].
35. Kao WY, Su CW, Chau GY, Lui WY, Wu CW, Wu JC*. A Comparison of
Prognosis between
Patients with Hepatitis B and C Virus-Related Hepatocellular Carcinoma
undergoing
Resection Surgery. World J Surg 2010 (in press).
邱士華教授：
1. Lo WL, Yu CC, Chen YW, Chiou GY, Huang PI, Tseng LM, Lu KH, Chang KW, Kao SY,
Chiou SH*. MicroRNA200c Attenuates tumor growth and metastasis of presumptive
head and neck squamous cell carcinoma stem cells. Journal of Pathology 2010 Nov 23.
[Epub ahead of print] (SCI: 6.4).
2. Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin
TW, Hsu HS, Wu CW. Embryonic Stem Cell Transcriptional Factor Oct4 and Nanog
Induced Epithelial-Mesenchymal Transition and Promoted Metastatic Ability in Lung
Adenocarcinoma. Cancer Research 2010 Dec 15;70(24):10433-44 (SCI: 7.83).
3. Wang CH, Chiou SH (Equal to First author), Chou CP, Chen YC, Huang YJ, Peng CA.
Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes
conjugated with CD133 monoclonal antibody. Nanomedicine. 2010 Jul 7. [Epub ahead of
print] (SCI: 5.98).
4. Chen YW, Chen KH, Huang PI, Chen YC, Chiou GY, Lo WL, Tseng LM, Hsu HS, Chang
KW, Chiou SH*. Cucurbitacin I Suppressed Stem-like Property and Enhanced
Radiation-induced Apoptosis in Head and Neck Squamous Carcinoma-derived
CD44+ALDH1+ Cells. Molecular Cancer Therapeutics 2010 Nov Epub (SCI: 5.003).
5. Chiou SH*, Chen SJ, Chang YL, Chen YC, Chen DT, Wang HH, Chen YJ, Lee HY, Ku
HH. MafA Promotes the Reprogramming of Placenta-derived Multipotent Stem Cells into
Pancreatic Progenitors and Insulin-positive Cells. Journal of Cellular and Molecular
Medicine 2010 Feb 16. [Epub ahead of print] (SCI: 6.73).
6. Hsu HS, Huang PI, Chang YL, Tzao C, Chen YW, Shih HC, Hung SC, Chen YC, Tseng
LM, Chiou SH*. Cucurbitacin I Inhibits Tumorigenic Ability and Enhances
Radiochemosensitivity in Non-Small Cell Lung Cancer-derived CD133+ Cells. Cancer
2011 Jan 10. [Epub ahead of print] (SCI: 5.4).
7. Li HY, Liao CY, Lee KH, Chang HC, Chen YJ, Chao KC, Chang SP, Chang CM, Sung YJ,
Chiou SH*. Collagen IV significantly enhances migration and transplantation of
embryonic stem cells: involvement of 21 integrin-mediated actin remodeling. Cell
Transplantation Cell Transplantation 2010 Dec 22. [Epub ahead of print] (SCI: 5.2).
8. Chen LH, Chiou GY, Chen YE, Li HY, Chiou SH*. microRNA and aging: A novel
modulator in regulating the aging network. Ageing Res Rev. 2010 Aug 12. [Epub
ahead of print]. (SCI:5.622)
9. Chen SJ, Tsai SK, Kao CL, Tai LT, Huang SS, Chou SJ, Li HY, Chang CM, Hung SC, Ku
HH, Chiou SH*. Functional Improvement of Focal Cerebral Ischemia Injury by Subdural
Transplantation of Induced Pluripotent Stem Cells with Fibrin Glue. Stem Cells and
Development 2010 Mar 1. [Epub ahead of print] (SCI: 4.1).
10. Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI, Lin SC, Liu CJ, Hu WY, Yu YH.
Epithelial-Mesenchymal Transition Mediator, S100A4, in Maintenance of Head and Neck
Cancer Initiating Cells. Cancer Research 2010 Dec 17. [Epub ahead of print] (SCI:
7.83).
11. Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, Chiou SH, Lin SC, Chang KW.
miR-31 Ablates Expression of the HIF Regulatory Factor FIH to Activate the HIF
Pathway in Head and Neck Carcinoma. Cancer Research 2010 Feb 9. (SCI: 7.83).
12. Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL. Ageing and neurodegenerative
diseases. Ageing Res Rev. 2010 Aug 21. [Epub ahead of print] (SCI:5.622)
13. Hung YT-Hung, HY-Li, Chen LL, Tsai KS, Chiou SH, KC-Chao, Hung SC.
Enhancement of wound healing by human multipotent stromal cell conditioned medium:
the paracrine factors and p38MAPK activation. Cell Transplantation. 2010 Dec 22.
[Epub ahead of print] (SCI: 5.2)
14. Yiin JJ, Hu B, Schornack PA, Sengar RS, Liu KW, Feng H, Lieberman FS, Chiou SH,
Sarkaria JN, Wiener ES, Ma HI, Cheng SY. ZD6474, a Multitargeted Inhibitor for
Receptor Tyrosine Kinases Suppresses Growth of Gliomas Expressing an EGFR Mutant,
EGFRvIII in the Brain. Molecular Cancer Therapeutics 2010 Apr;9(4):929-41. (SCI:
5.003).
15. Peng YJ, Wen CW, Chiou SH, Liu SJ. Sustained release of ganciclovir and foscarnet from
biodegradable scleral plugs for the treatment of cytomegalovirus retinitis. Biomaterials
2010 Mar;31(7):1773-9. Epub 2009 Dec 7. (SCI: 6.87).
16. Hsu HS, Kin JH, Tsai KS, Chen LL, Chiou SH, Hung SC. (2010) Chemo-resistance of
Lung Cancer Stem-like Cells Depends on Activation of Hsp27. Cancer 2010 Nov 8.
[Epub ahead of print] (SCI: 5.4).
17. Chen YJ, Li HY, Chang YL, Lu KH, Tai LK, Yuan CC, Chang CM, Chiou SH*.
Suppression
of
migratory/invasive
ability
and
induction
of
apoptosis
in
adenomyosis-derived mesenchymal Stem cells by cyclooxygenase-2 inhibitors. Fertility
and Sterility 2010 Mar 11 [Epub ahead of print] (SCI:4.1; Rank: 3/61)
18. Li HY, Chen YJ, Chen SJ, Kao CL, Tseng LM, Lo WL, Chang CM, Yang DM, Ku HH,
Chiou SH (Co-corresponding author)*, Chang YL. Induction of Insulin-Producing
Cells Derived from Endometrial Mesenchymal Stem-like Cells. J Pharmacol Exp Ther
2010 Sep 20. [Epub ahead of print] (SCI: 4.13).
19. Ma HI, Chiou SH, Hueng DY, Tai LK, Huang PI, Kao CL, Chen YW, Sytwu HK.
Celecoxib Improved Radiotherapeutic Effects in Radioresistant Glioblastoma-derived
CD133+ Cells. J Neurosurgery 2010 Nov 5. [Epub ahead of print] (SCI: 2.6).
20. Chen KH, Hsu CC, Song WS, Huang CS, Tsai CC, Kuo CD, Hsu HS, Tsai TH, Tsai CY,
Woung LC, Chiou SH*, Lu KH, Chen YW. Celecoxib enhances radiosensitivity in
medulloblastoma- derived CD133-positive cells. Childs Nerv Syst. 2010 Jun 5. [Epub
ahead of print] (SCI: 1.35).
21. Yu CC, Chiou GY, Lee YY, Chang YL, Huang PI, Cheng YW, Tai LK, Ku HH, Chiou SH*,
Wong TT. Medulloblastoma-derived Tumor Stem-like Cells Acquired Resistantance to
TRAIL-induced Apoptosis and Radiosensitivity. Childs Nerv Syst 2010 Feb 24. [Epub
ahead of print] (SCI: 1.35).
22. Chen YC, Chang CY, Hsu HS, Chen YW, Tai LT, Tseng LM, Chiou GY, Chang SC, Kao
SY, Chiou SH (Co-corresponding author)*, Lo WL. Inhibition of tumorigenicity and
enhancement of radiochemosensitivity in head and neck squamous cancer-derived
ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol. 2010 Mar;46(3):158-165.
Epub 2009 Dec 29 (SCI: 3.1).
23. Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KS, Chou SJ, Chang YL, Ku HH, Li HY.
Resveratrol Promotes Osteogenic Differentiation and Protects Against Dexamethasone
Damage in Induced Pluripotent Stem Cells. Stem Cells and Development 2010:247-58.
(SCI: 4.1).
24. Chen CY, Chiou SH, Huang CY, Jan CI, Lin SC, Hu WY, Chou SH, Liu CJ, Lo JF. Tid1
Functions as a Tumor Suppressor in Head and Neck Squamous Cell Carcinoma. J Pathol
2009 Nov;219(3):347-55 (SCI: 5.4).
25. Kao CL, Huang PI, Tsai PH, Tsai ML, Lo JF, Chen YW, Chiou SH*. Resveratrol-Induced
Apoptosis and Increased Radiosensitivity in CD133-positive Cells Derived from Atypical
Teratoid/Rhabdoid Tumor. Int J Radiat Oncol Biol Phys 2009;74(1):219-28. (SCI: 4.63).
26. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC. A
Comprehensive Analysis of the Independent Effect of Twist and Snail in Promoting
Metastasis of Hepatocellular Carcinoma. Hepatology 2009;50(5):1464-1474 (SCI:
11.355).
27. Yang DM, Teng HC, Chen KH, Tsai ML, Lee TK, Chou YC, Chi CW, Chiou SH
(Co-coresponding author)*, Lee CH. Clodronate-induced cell apoptosis in human
thyroid carcinoma is mediated via the P2 receptor signaling pathway. J Pharmacol Exp
Ther. 2009 Aug;330(2):613-23. (SCI: 4.308)
28. Yen SH, Chen YW, Huang PI, Wong TT, Ho DM, Chang KP, Liang ML, Chiou SH, Lee
YY, Chen HH. The Optimal Treatment for Intracranial Germinoma – Can We Lower The
Radiation Dose Without Chemotherapy? Int J Radiat Oncol Biol Phys 2009 Oct 26.
[Epub ahead of print] (SCI: 4.6)
29. Chen CY; Chiou SH; Huang CY; Jan CI; Lin SC; Tsai ML; Lo JF. Distinct population of
highly malignant cells in a head and neck squamous cell carcinoma cell line established
by xenograft model. Journal of Biomedical Science 2009 Nov 16;16(1):100 (SCI:
2.01).
30. Chen YC, Chen YW, Hsu HS, Tseng LM, Huang PI, Lu KS, Tai LK, Yung MC, Chang SC,
Ku HH, Chiou SH (Co-coresponding author)*, Lo WL. Aldehyde Dehydrogenase 1 Is a
Putative Marker for Cancer Stem Cells in Head and Neck Squamous Cancer. Biochem
Biophys Res Commun. 2009 Jul 31;385(3):307-13. (SCI: 2.8)
31. Chuang CY , Chiou SH (co-first author), Yang WE, Hsu ML, Yung MC, Tsai ML, Chen
LK, Hung HH. Formation of TiO2 nano-network on titanium surface increases the human
cell growth. Dental Materials 2009 Aug;25(8):1022-9. (SCI: 3.30)
32. Chang CJ, Hsu CC, Yung MC, Chen KY, Tzao C, Wu WF, Chou HY, Lee YY, Lu KH,
Chiou SH (Co-coresponding author)*, Ma HI. Enhanced radiosensitivity and
radiation-induced apoptosis in glioma CD133-positive cells by knockdown of SirT1
expression. Biochem Biophys Res Commun. 2009 Mar 6;380(2):236-42. (SCI: 2.8)
33. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Chien CS, Ku HH, Lo JF. Positive
Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High Grade Oral
Squamous Cell Carcinoma. Clinical Cancer Research 2008;14(13):4085-95 (SCI: 6.3)
34. Yang
MH,
Chang
SY,
Chiou
SH,
et
al.
Hypoxia
and
HIF1a
induces
epithelial-mesenchymal transition and co-expression of Twist and Snail predicts
metastatsis of head and neck cancer. Nature Cell Biology 2008 Mar;10(3):295-305.
(SCI:18.5).
35. Chen YC, Hsu HS, Chen YW, Tsai TH, How CK, Wang CY, Chang YL, Tsai ML, Lee YY,
Chiou SH*. Oct-4 Expression Maintained Cancer Stem-like Properties in Lung
Cancer-derived CD133-positive Cells. PLoS ONE 2008 July 9;3(7):e2637. (SCI: 4.36)
36. Chiou SH*, Kao CL, Lo JF, Tsai ML, Ku HH, Hsu MT, Wong TT. CD133-positive
atypical teratoid/rhabdoid tumor cells promote radioresistance by activation of
ATM-related response and antiapoptotic activity. PLoS ONE 2008 May 7;3(5):e2090.
(SCI: 4.36)
37. Huang TF, Chen YT, Yang TH, Chen LL, Chiou SH, Tsai TH, Tsai CC, Chen MH, Ma HL,
Hung SC. Isolation and characterization of mesenchymal stromal cells from human
anterior cruciate ligament. Cytotherapy 2008;10(8):806-14. (SCI:3.5)
38. Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, Hung SC. cAMP/PKA Regulates
Osteogenesis, Adipogenesis and Ratio of RANKL/OPG mRNA Expression in
Mesenchymal Stem Cells by Suppressing Leptin. PLoS ONE 2008 Feb 6;3(2):e1540.
(SCI: 4.36)
39. Huang TS, Hsieh JY, Wu YH, Jen CH, Tsuang YH, Chiou SH, et al. Functional network
reconstruction reveals somatic stemness genetic maps and dedifferentiation-like
transcriptome reprogramming induced by GATA2. Stem Cells 2008;26:1186-201.
(SCI:7.7)
40. P-S Hung, S-Y Kao, Y-H Shih, S-H Chiou, C-J Liu, K-W Chang, S-C Lin. Insulin-like
growth factor binding protein-5 suppresses the tumourigenesis of head and neck
squamous cell carcinoma. Journal of Pathology 2008 Feb;214(3):368-76. (SCI: 5.2).
41. Peng CH, Chiou SH (co-first author), Chen SJ, et al. Neuroprotection by Imipramine
Against Lipopolysaccharide-induced Apoptosis in Hippocampus-derived Neural Stem
Cells Mediated by Activation of BDNF and the MAPK pathway. European
Neuropsychopharmacology 2008 Feb;18(2):128-40. (IF:4.4).
42. Perng CK , Kao CL, Yang YP, Ku HH, Chiou SH*. Culturing Adult Human Bone Marrow
Stem Cells on Gelatin Scaffold with pNIPAAm as Transplanted Grafts for Skin
Regeneration. Journal of Biomedical Materials Research: Part A 2008;84(3):622-30.
43. Chang YF, Teng HC, Cheng SY, Wang CT, Chiou SH, Kao LS, Kao FJ, Yang DM.
Orai1-STIM1 formed Store-Operated Ca2+ Channels as the Molecular Components
needed for Pb2+ Entry in Living Cells. Toxicology and Applied Pharmacology 2008 Mar
15;227(3):430-9. (SCI:4.8)
44. Lin HL, Yang MH, Wu CW, Chen PM, Yang YP, Kao CL, Ku HH, Lo JF, Liou JP, Chi CW,
Chiou SH*. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathwaymediated metastasis of gastric cancer. Int J Cancer 2007;121(11):2547-55 (SCI:4.73).
45. Yang MH, Chang SY, Chiou SH, et al. Overexpression of NBS1 induces
epithelial-mesenchymal transition and co-expression of NBS1 and Sanil predicts
metastatsis of head and neck cancer. Oncogene 2007;26:1459-1467 (SCI:7.2).
46.
Lin HL, Chiou SH (co-first author), Wu CW, Lin WB, Chen LH, Yang YP, Tsai ML, Uen
YH, Liou JP, Wu CW, et al. Combretastatin A4-induced Differential Cytotoxicity and
Reduced Metastatic Ability by Inhibition of AKT Function in Human Gastric Cancer
Cells. J Pharmacology & Experimental Therapeutics 2007;323(1):365-73. (SCI: 4.12).
47. Chang CM, Kao CL, Chang YL, Yang MC, Chen YC, Chao KC, Chiou SH*, Ku HH.
Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells.
Biochem Biophys Res Commun 2007;357(2):414-20. (SCI:2.8).
48. S-H Chiou, C-L Kao, Y-L Chang, C-J Yen, T-H Tsai. Evaluation of anti-FasL-induced
apoptosis and neural differentiation of PC12 Cell treated by NGF using siRNA method and
sampling by microdialysis. Analytical Biochemistry 2007;363:46-57 (SCI:3.088; 8/46).
49. Chen SJ, Yen CJ, Peng CH, Chien CS, Chen IL, Chang YL, Ku HH, Chiou SH*.
Antidepressant administration modulates neural stem cell survival and components of
differentiation through Bcl-2. Current Neurovascular Research 2007;4(1):19-29
(SCI:3.571
楊慕華副教授：
1. Yang MH*, Hsu DS, Wang HW, Wang SJ, Lan HY, Yang WH, Huang CH,
Kao SY, Tzeng CH, Tai SK, Chang SY, Lee OK, Wu KJ*. Bmi1 is essential
in Twist1-induced epithelial-mesenchymal transition. Nat Cell Biol
2010;12:982-92. (*corresponding author)(IF=19.527, rank 6/161 of Cell
Biology)
2. Hsu DS, Lan HY, Huang CH, Tai SK, Chang SY, Tsai TL, Chang CC,
Tzeng CH, Wu KJ, Kao JY*, Yang MH*. Regulation of excision repair
cross-complementation group 1 (ERCC1) by Snail contributes to cisplatin
resistance in head and neck cancer. Clin Cancer Res 2010;16:1561-1571.
(*corresponding author)(IF=6.747, rank 16/165 of Oncology).
3. Chen YJ, Li SY, Huang CH, Twu NF, Yen MS, Wang PH, Chou TY, Liu YN,
Chao KC, Yang MH*. Oestrogen-induced epithelial-mesenchymal
transition of endometrial epithelial cells contributes to the development of
adenomyosis.
J
Pathol
2010;222:261-270.(*corresponding
author)(IF=6.466, rank 2/71 of Patholgoy)
4. Hsu DS, Chang SY, Liu CJ, Tzeng CH, Wu KJ, Kao JY*, Yang MH*.
Identification of increased NBS1 expression as a prognostic marker of
squamous cell carcinoma of oral cavity. Cancer Sci 2010; 101:1029-1037.
(*corresponding author)(IF=3.771, rank 51/165 of Oncology)
5. Huang YC, Chang PM, Lee IC, Yang CF, Tzeng CH, Yang MH*. Duodenal
squamous cell carcinoma derived from the hypopharynx immunohistochemical assessment of metastatic mechanisms. Gastrointest
Endosc 2010; 72:460-463(* corresponding author)(IF=6.713, rank 5/65
of Gastroenterology).
6. Yang MH, Chang PM, Tzeng CH, Chang SY, Chu PY, Tai SK, Tsai TL,
Wang YF, Huang JL, Wang HM, Chen PM. Promising overall survival of
patients with recurrent/metastatic squamous cell carcinoma of head and
neck receiving gemcitabine plus cisplatin treatment: report of a multi-center
phase II study. Cancer Chemother Pharmacol 2010; 65: 259-265.(IF=2.654,
rank 96/236 of Pharmacology)
7. Chen MH, Chang PM, Chen PM, Tzeng CH, Chu PY, Chang SY, Yang
MH*. Prolonged facial edema is an indicator of poor prognosis in patients
with head and neck squamous cell carcinoma. Support Care Cancer 2010;
18:1313-1319 (* corresponding author)(IF=2.089, rank 8/33 of
Rehabilitation). 1 citation.
8. Huang CH, Chen PM, Lu TC, Kung WM, Chiou TJ, Yang MH, Kao JY,
Wu KJ. Purified Recombinant TAT-HOXB4 expands CD34+ Umbilical
Cord Blood and Peripheral Blood Progenitor Cells ex vivo. Tissue Eng Part
C Methods 2010; 16:487-496.(IF=2.291, rank 62/291 of Biotechnology &
Applied Microbiology)
9. Huang CC, Yang WH, Chang SY, Tai SK, Tzeng CH, Kao JY, Wu KJ*,
Yang MH*. Regulation of membrane-type 4 matrix metalloproteinase
(MT4-MMP) by SLUG contributes to hypoxia-mediated metastasis.
Neoplasia 2009;11:1371-82.(* corresponding author)(IF=5.025, rank
25/165 of Oncology). 4 citations.
10. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu
JC. Comprehensive analysis of the independent effect of Twist and Snail in
promoting metastasis of hepatocellular carcinoma. Hepatology 2009;
50:1464-1474.(IF=10.840, rank 2/65 of Gastroenterology). 22 citations.
11. Hung JJ, Yang MH, Hsu HH, Hsu WH, Wu KJ. Prognostic significance of
hypoxia-inducible factor-1 alpha, TWIST1 and Snail expression in
resectable non-small cell lung cancer. Thorax 2009; 64:1082-9. 3 citations.
(IF=7.041, rank 2/43 of Respiratory System)
12. Chen MH, Chang PM, Chen PM, Tzeng CH, Chu PY, Chang SY, Yang
MH*. Prognostic significance of a pretreatment hematologic profile in
patients with head and neck cancer. J Cancer Res Clin Oncol
2009;135:1783-90. (*corresponding author)(IF=2.261, rank 88/165 of
Oncology). 5 citations.
13. Tsai YP, Yang MH, Huang CH, Chang SY, Chen PM, Liu CJ, Teng SC, Wu
KJ. Interaction between HSP60 and beta-catenin promotes metastasis.
Carcinogenesis 2009; 30: 1049-57.(IF=4.795, rank 28/165 of Oncology). 2
citations.
14. Liu CY, Huang LJ, Wang WS, Chen TL, Yen CC, Yang MH, Hsiao LT, Liu
CY, Chen PM, Chiou TJ. Candidemia in cancer patients: impact of early
removal of non-tunneled central venous catheters on outcome. J Infect 2009;
58: 154-60. 3 citations. (IF=3.060, rank 15/57 of Infectious Disease)
15. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu
KJ. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat
Cell Biol 2008; 10:295-305. 135 citations. (IF=19.527, rank 6/161 of Cell
Biology)
16. Yang MH, Wu KJ. TWIST activated by hypoxia inducible factor-1 (HIF-1):
implication in metastasis and development. Cell Cycle 2008; 7:2090-2096.
23 citations. (IF=4.087, rank 59/166 of Cell Biology)
17. Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL,
Wang YF, Chang SY*, Yang MH*. Effectiveness of pharmacokinetic
modulating chemotherapy combined with cisplatin as induction
chemotherapy in resectable locally advanced head and neck cancer: phase II
study. Cancer Chemother Pharmacol 2008; 63:9-17. (*corresponding
author)(IF=2.654, rank 96/236 of Pharmacology)
18. Chen PM, Yen CC, Wang WS, Lin YJ, Chu CJ, Chiou TJ, Liu JH, Yang
MH*. Down-regulation of Notch-1 expression decreases PU.1-mediated
myeloid differentiation signaling in acute myeloid leukemia. Int J Oncol
2008; 32:1335-41. 6 citations. (*corresponding author)(IF=2.447, rank
82/165 of Oncology).
19. Chang PM, Chen PM, Hsieh SL, Tzeng CH, Liu JH, Chiou TJ, Wang WS,
Yen CC, Gau JP, Yang MH*. Expression of a soluble decoy receptor 3
(DcR3) in patients with diffuse large B cell lymphoma (DLBCL) predicts
clinical outcome. Int J Oncol 2008; 33;549-554. 8 citations.
(*corresponding author)(IF=2.447, rank 82/165 of Oncology).
20. Chen YC, Chiang HY, Yang MH, Chen PM, Chang SY, Teng SC,
Vanhaesebroeck B, Wu KJ. Activation of phosphoinositide 3-kinase by
the NBS1 DNA repair protein through a novel activation motif. J Mol Med
2008; 86:401-12. 10 citations. (IF=5.004, rank 14/92 of Medicine,
Research & Experimental) .
蘇建維醫師：
1. Huo TI, Huang YH, Su CW, Lin HC, Chiang JH, Chiou YY, Huo SC, Lee PC,
Lee SD. Validation of the HCC-MELD for dropout probability in patients with
small hepatocellular carcinoma (HCC) undergoing locoregional therapy. Clin
Transplant 2008;22:469-475 (SCI, IF: 2.004) (The first three authors [Huo TI,
Huang YH and Su CW] have contributed equally to this work). 6 citations.
2. Su CW, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Lee PC, Lee SD, Wu
JC. Natural history and prognostic factors of primary biliary cirrhosis in
Taiwan: A follow-up study up to 18 years. Liver Int 2008;28:1305-1313. 4
citations. (SCI, IF: 2.987)
3. Su CW, Chan CC, Hung HH, Huo TI, Huang YH, Li CP, Lin HC, Tsay SH,
Lee PC, Lee SD, Wu JC. Predictive value of aspartate aminotransferase to
alanine aminotransferase ratio (AAR) for hepatic fibrosis and clinical adverse
outcomes in patients with primary biliary cirrhosis. J Clin Gastroenterol
2009;43:876-883. 2 citations. (SCI, IF: 2.207).
4. Wu JC, Huang YH, Chau GY, Su CW, Lai CR, Lee PC, Huo TI, Sheen IJ, Lee
SD, Lui WY. Risk factors for early and late recurrence in hepatitis B-related
hepatocellular carcinoma. J Hepatol 2009;51:890-897. 12 citations. (SCI, IF
7.818).
5. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu
JC. A Comprehensive analysis of the independent effect of Twist and Snail in
promoting metastasis of
hepatocellular carcinoma. Hepatology 2009;
50:1464-1474. 22 citations. (SCI, IF: 10.840).
6. Hsu CY, Huang YH, Su CW, Lin HC, Chiang JH, Lee PC, Lee FY, Huo TI,
Lee SD. Renal failure in patients with hepatocellular carcinoma and ascites
undergoing transarterial chemoembolization. Liver Int 2010;30:77-84. 3
citations. (SCI, IF: 2.987)
7. Hsu CY, Lin HC, Huang YH, Su CW, Lee FY, Huo TI, Lee PC, Lee SD.
Comparison of the model for end-stage liver disease (MELD), MELD-Na and
MELDNa for outcome prediction in patients with acute decompensated
hepatitis. Digest Liver Dis 2010:42:137-142. 2 citations. (SCI, IF: 2.972).
8. Hsu CY, Huang YH, Hsia CY, Su CW, Lin HC, Loong CC, Chiou YY, Chiang
JH, Lee PC, Huo TI, Lee SD. A new prognostic model for hepatocellular
carcinoma based on total tumor volume: the Taipei integrated scoring system.
J Hepatol 2010;53:108-117. 1 citation. (SCI, IF 7.818).
9. Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Lee PC, Loong CC, Chiang
JH, Huo TI, Lee SD. Selecting an optimal staging system for hepatocellular
carcinoma: comparison of 5 currently used prognostic models. Cancer 2010;
116:3006-3014 (SCI, IF: 5.418).
10. Hsu CY, Huang YH, Su CW, Chiang JH, Lin HC, Lee PC, Lee FY, Huo TI,
Lee SD. Transarterial chemoembolization in patients with hepatocellular
carcinoma and renal insufficiency. J Clin Gastroenterol 2010;44:e171-177
(SCI, IF: 2.207).
11. Hung HH, Su CW, Lai CR, Chau GY, Chan CC, Huang YH, Huo TI, Lee PC,
Kao WY, Lee SD, Wu JC. Fibrosis and AST to platelet ratio index predict
post-operative prognosis for solitary small hepatitis-B related hepatocellular
carcinoma. Hepatol Int 2010;4:691-699 (SCI, IF: 1.725) (The first two authors
[Hung HH and Su CW] have contributed equally to this work).
12. Hung HH, Chiou YY, Hsia CY, Su CW (corresponding author), Chou YH,
Chiang JH, Huo TI, Huang YH, Su YH, Lin HC, Lee SD, Wu JC. Survival
rates are comparable following radiofrequency ablation or surgery in patients
with small hepatocellular carcinomas. Clin Gastroenterol Hepatol (SCI, IF:
5.642) (in press) .
顏厥全醫師：
1. Yen CC, Tsao YP, Chen P CH, Wu YC, Liu JH, Pan CC, Liu CY, Tzeng CH,
Chen PM, Chen YJ, Lin CH, Hsu WH. PML protein as a prognostic
molecular marker for patients With esophageal squamous cell carcinomas
receiving primary surgery. J Surg Oncol. 2011 (in press) (IF: 2.502, 37/167,
Surgery)
2. Teng HW, Wang HW, Chen WM, Chao TC, Hsieh YY, Hsih CH, Tzeng CH,
Chen P CH, Yen CC.* Prevalence and prognostic influence of genomic
changes of EGFR pathway markers in synovial sarcoma. J Surg Oncol.
2011 (in press) (IF: 2.502, 37/167, Surgery)
3. Liu CY, Yen CC,* Chen WM, Chen TH, Chen PC, Wu HT, Shiau CY, Wu
YC, Liu CL, Tzeng CH. Soft tissue sarcoma of extremities: the prognostic
significance of adequate surgical margins in primary operation and
reoperation after recurrence. Ann Surg Oncol. 2010 Aug;17(8):2102-11. (IF:
4.130, 6/167, Surgery)
4. Liu CC, Liu JH, Wu SC, Yen CC, Chen WS, Tsai YC. A novel
E1B-55kD-deleted oncolytic adenovirus carrying mutant KRAS-regulated
hdm2 transgene exerts specific antitumor efficacy on colorectal cancer cells.
Mol Cancer Ther. 2010 Feb;9(2):450-60. (IF: 4.953, 28/166, Oncology)
5. Yen CC, Chen WM, Chen TH, Chen WYK, Chen PCH, Chiou H-J et al.
Identifications of chromosomal aberrations associated with disease
progression and a novel 3q13.31 deletion involving LSAMP gene in
osteosarcoma. Int J Oncol. 2009 Oct;35(4):775-88. 2 citations. (IF: 2.447,
83/166, Oncology)
6. Wong FH, Huang CYF, Su LJ, Wu YC, Lin YS, Hsia JY, Tsai HT, Lee SA,
Lin CH, Chen PM, Chen YJ, Liang SC, Lai JM, Yen CC.* Combination of
microarray profiling and protein-protein interaction databases delineates the
minimal discriminators as a metastasis network for esophageal squamous
cell carcinoma. Int J Oncol. 2009 Jan;34(1):117-28. 5 citations. (IF: 2.447,
83/166, Oncology)
7. Chen PM, Yen CC, Wang WS, Lin YJ, Chu CJ, Chiou TJ, Liu JH, Yang
MH. Down-regulation of Notch-1 expression decreases PU.1-mediated
myeloid differentiation signaling in acute myeloid leukemia. Int J Oncol.
2008 Jun; 32(6):1335-41. 4 citations. (IF: 2.447, 83/166)
8. Lee MY, Yang MH, Liu JH, Yen CC,* Lin PC, Teng HW, Wang WS, Chiou
TJ, Chen PM. Severe anaphylactic reactions in patients receiving oxaliplatin
therapy: a rare but potentially fatal complication. Support Care Cancer. 2007
Jan;15(1):89-93, Jul 25. 12 citations. (IF: 2.089. 8/33, rehabilitation)
9. Yen CC, Liang SC, Jong YJ, Chen YJ, Lin CH, Chen YM, Wu YC, Su WC,
Huang CY, Tseng SW, Whang-Peng J. Chromosomal aberrations of
malignant pleural effusions of lung adenocarcinoma: Different cytogenetic
changes are correlated with genders and smoking habits. Lung Cancer. 2007
Sep;57(3):292-301. 4 citations. (IF: 3.140, 10/43, respiratory system)